Published in J Pharm Sci on November 01, 1982
Effect of surgery and cardiopulmonary bypass on indocyanine green pharmacokinetics. Tex Heart Inst J (1986) 0.77
Transpulmonary pharmacokinetics of an ACE inhibitor (perindoprilat) in man. Br J Clin Pharmacol (1991) 0.77
Pharmacokinetic and metabolic aspects of the moclobemide-food interaction. Psychopharmacology (Berl) (1992) 0.75
Cervical screening and health inequality in England in the 1990s. J Epidemiol Community Health (2003) 2.67
Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis (2010) 2.60
Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol (1970) 2.58
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.35
Cloning and characterization of a phosphopantetheinyl transferase from Streptomyces verticillus ATCC15003, the producer of the hybrid peptide-polyketide antitumor drug bleomycin. Chem Biol (2001) 2.25
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med (1981) 2.15
A double-blind study of the effectiveness of a high-efficiency particulate air (HEPA) filter in the treatment of patients with perennial allergic rhinitis and asthma. J Allergy Clin Immunol (1990) 1.72
Stimulation of leukocyte adenyl cyclase by hydrocortisone and isoproterenol in asthmatic and nonasthmatic subjects. J Allergy Clin Immunol (1972) 1.71
Vancomycin anaphylaxis and successful desensitization. Ann Allergy (1994) 1.64
Autonomic imbalance in asthma with special reference to beta adrenergic blockade. Adv Intern Med (1972) 1.56
Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism. Clin Pharmacol Ther (1978) 1.51
Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol (1994) 1.45
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon. Clin Pharmacol Ther (1983) 1.43
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos (1997) 1.43
Antiviral effect of flavonoids on human viruses. J Med Virol (1985) 1.43
The anatomical and biochemical basis of bronchial obstruction in asthma. Ann Intern Med (1965) 1.42
Problems in regaining full extension of the knee after anterior cruciate ligament reconstruction: does arthrofibrosis exist? Knee Surg Sports Traumatol Arthrosc (1994) 1.41
Primary Cancer of the Lung. Cal West Med (1945) 1.38
Vancomycin pharmacokinetics in burn patients and intravenous drug abusers. Antimicrob Agents Chemother (1990) 1.32
Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects. Clin Pharmacol Ther (1989) 1.32
Antiasthmatic drug therapy and calcium ions: review of pathogenesis and role of calcium. J Pharm Sci (1980) 1.28
Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther (1995) 1.28
Metabolic response to epinephrine in bronchial asthma. J Allergy (1968) 1.26
Allergy-related diseases and cancer: an inverse association. Am J Epidemiol (1985) 1.25
Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit (1994) 1.24
Alpha1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther (1982) 1.23
Inhibition of drug metabolism by quinolone antibiotics. Clin Pharmacokinet (1988) 1.20
Effects of a three-year exercise program on motor function and cognitive processing speed in older women. Res Q Exerc Sport (1991) 1.19
Individualization of phenytoin dosage regimens. Clin Pharmacol Ther (1977) 1.17
Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporos Int (2006) 1.17
Trough concentrations of cyclosporine in blood following administration with grapefruit juice. Br J Clin Pharmacol (1993) 1.15
IgE levels in sera of children with asthma. Pediatrics (1971) 1.15
Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol (1989) 1.15
Cost effectiveness of the Expert Patients Programme (EPP) for patients with chronic conditions. J Epidemiol Community Health (2008) 1.15
A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. Am Rev Respir Dis (1989) 1.14
Increased theophylline concentrations secondary to ciprofloxacin. Drug Intell Clin Pharm (1987) 1.13
Influence of food on the presystemic metabolism of drugs. Pharmacol Ther (1988) 1.12
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther (1993) 1.10
Ascorbic acid-enhanced antiproliferative effect of flavonoids on squamous cell carcinoma in vitro. Anticancer Drugs (1993) 1.10
Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr (1982) 1.08
A model of insulin fibrils derived from the x-ray crystal structure of a monomeric insulin (despentapeptide insulin). Proteins (1997) 1.07
Effect of hydrocortisone on immunoglobulin synthesis and secretion by human peripheral lymphocytes in vitro. Int Arch Allergy Appl Immunol (1972) 1.06
Effect of enoxacin and 4-oxo-enoxacin on antipyrine disposition in the rat. Drug Metab Dispos (1988) 1.04
Free drug concentration monitoring in clinical practice. Rationale and current status. Clin Pharmacokinet (1987) 1.04
Vancomycin protein binding in patients with infections caused by Staphylococcus aureus. DICP (1991) 1.03
Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol (1999) 1.03
Quercetin: an inhibitor of antigen-induced human basophil histamine release. J Immunol (1981) 1.03
Effect of norfloxacin on theophylline pharmacokinetics at steady state. Antimicrob Agents Chemother (1988) 1.02
Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking. J Pharmacokinet Biopharm (1994) 1.02
Letter: Absolute drug bioavailability: approximation without comparison to parenteral dose for compounds exhibiting perturbable renal clearance. J Pharm Sci (1974) 1.02
Role of calcium and calcium antagonists in airway function. Eur J Respir Dis Suppl (1983) 1.02
Therapeutic drug monitoring in saliva. An update. Clin Pharmacokinet (1992) 1.02
Absorption kinetics of procainamide in humans. J Pharm Sci (1977) 1.02
Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim. Am J Hematol (2001) 1.02
Effect of food on lidocaine kinetics: mechanism of food-related alteration in high intrinsic clearance drug elimination. Clin Pharmacol Ther (1981) 1.01
A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol (2000) 1.01
Factors influencing serum protein binding of lidocaine in humans. Anesth Analg (1981) 0.99
Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochem Pharmacol (1984) 0.98
One brief exposure to a psychological stressor induces long-lasting, time-dependent sensitization of both the cataleptic and neurochemical responses to haloperidol. Life Sci (1992) 0.97
Clinical pharmacokinetics of oral cephalosporins. Antibiot Chemother (1971) (1995) 0.96
Effects of flavonoids and transitional metal cations on antigen-induced histamine release from human basophils. Biochem Pharmacol (1982) 0.96
Contrasting effects of fluconazole and ketoconazole on phenytoin and testosterone disposition in man. Br J Clin Pharmacol (1992) 0.96
Effect of carbohydrates on estimated hepatic blood flow. Clin Pharmacol Ther (1984) 0.95
Discordant allergic manifestations in monozygotic twins: genetic identity versus clinical, physiologic, and biochemical differences. J Allergy (1971) 0.95
Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues. Biochemistry (1998) 0.95
Effects of smooth muscle calcium antagonists on human basophil histamine release. Biochem Pharmacol (1981) 0.94
Effect of adrenergic compounds, aminophylline and hydrocortisone, on in vitro immunoglobulin synthesis by normal human peripheral lymphocytes. J Allergy Clin Immunol (1973) 0.94
The biosynthetic gene cluster for the anticancer drug bleomycin from Streptomyces verticillus ATCC15003 as a model for hybrid peptide-polyketide natural product biosynthesis. J Ind Microbiol Biotechnol (2001) 0.93
The effect of phentolamine on adenylate cyclase and on isoproterenol stimulation in leukocytes from asthmatic and nonasthmatic subjects. J Allergy Clin Immunol (1973) 0.93
Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone. Clin Pharmacol Ther (1991) 0.92
Recent advances: the cytochrome P450 enzymes. Ann Pharmacother (1995) 0.92
Regulatory role of prostaglandin E in allergic histamine release with observations on the responsiveness of basophil leukocytes and the effect of acetylsalicylic acid. J Allergy Clin Immunol (1977) 0.92
Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557. Antimicrob Agents Chemother (2009) 0.92
Fatal varicella in a corticosteroid-dependent asthmatic receiving troleandomycin. Allergy Proc (1990) 0.92
Determination of hydralazine and its metabolites by gas chromatography-mass spectrometry. J Chromatogr (1976) 0.92
Kinetics of the oral antiarrhythmic lidocaine congener, tocainide. Clin Pharmacol Ther (1976) 0.91
Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm. Clin Pharmacol Ther (1992) 0.90
Disodium cromoglycate in bronchial asthma. Ann Intern Med (1969) 0.90
Endometrial cancer metastasis presenting as a grossly swollen toe. Int J Gynecol Cancer (2003) 0.90
Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin. Clin Pharmacol Ther (1995) 0.90
Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man. J Pharmacokinet Biopharm (1992) 0.90
Bioavailability of syrup and tablet formulations of cefetamet pivoxil. Antimicrob Agents Chemother (1993) 0.90
Newer drugs in management. Calcium antagonists. Chest (1985) 0.90
Prior stress attenuates the analgesic response but sensitizes the corticosterone and cortical dopamine responses to stress 10 days later. Psychopharmacology (Berl) (1989) 0.90
Airway smooth muscle in exercise-induced bronchospasm: some speculations. Pediatrics (1975) 0.90
Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype. Pharmacogenetics (2000) 0.90
Aromatic acids derived from phenylalanine in the tissues of rats with experimentally induced phenylketonuria-like characteristics. Biochem J (1972) 0.89
In vitro interactions between beta-lactam antibiotics and tobramycin. Clin Chem (1981) 0.89
Factors affecting quinidine protein binding in humans. J Pharm Sci (1984) 0.89